Literature DB >> 21082563

Routine hiatal hernia repair in laparoscopic gastric banding.

Jonathan Reich1, Karl Strom, James Pasquariello, Silvia Fresco, Joseph Barbalinardo.   

Abstract

Laparoscopic gastric banding is now well established as an effective means of obtaining safe, healthy weight loss in the morbidly obese patient population. The procedure has evolved over the years to minimize complications and optimize results. Preoperative patient evaluation includes upper endoscopy to assess the baseline integrity of the stomach and rule out pathology. Upper endoscopy fails to demonstrate the majority of small hiatal hernias in these patients preoperatively. Hiatal hernias are grossly underappreciated in patients with morbid obesity due to the presence of a large distal esophageal fat pad. With post-operative internal weight loss, a small crural defect can become relatively large in a short amount of time. Performing gastric banding without dissecting and repairing the hiatal hernia can lead to incorrect positioning of the gastric band, which is associated with poor weight loss, chronic reflux, and increased complications. Concomitant hiatal hernia repair is felt by the authors to be a necessary component for the correct placement of the gastric band device, which, in turn, provides excellent long-term results to our patients.

Entities:  

Mesh:

Year:  2010        PMID: 21082563

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  2 in total

1.  Preoperative Endoscopic and Radiologic Evaluation of Bariatric Patients: What Do They Add?

Authors:  Iman Ghaderi; Amlish B Gondal; Julia Samamé; Federico Serrot; Carlos A Galvani
Journal:  J Gastrointest Surg       Date:  2019-05-09       Impact factor: 3.452

2.  Location and number of sutures placed for hiatal hernia repair during laparoscopic adjustable gastric banding: does it matter?

Authors:  Nabeel R Obeid; Spencer Deese-Laurent; Bradley F Schwack; Heekoung Youn; Marina S Kurian; Christine Ren-Fielding; George A Fielding
Journal:  Surg Endosc       Date:  2013-09-06       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.